| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42c74bfd74b8e91469ba3975345e4c78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27c2d7c182c2ee0eb7999305a767fd58 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-213
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-213
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6574 |
| filingDate |
2019-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b386f70093b2fd24fca8e5dd22aa0980
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e330f00f27a111b252ba7ca76b0e79ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d72fde264c8ee66d8287d0c4aeb4b61 |
| publicationDate |
2020-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-111655712-A |
| titleOfInvention |
Compounds as tumor immune compounds and their applications |
| abstract |
The compound represented by the formula (I), its optical isomer and its pharmaceutically acceptable salt, and the application of the compound as a STING agonist are disclosed. (I) |
| priorityDate |
2018-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |